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Summary: A spectrum of quantitative methods was adapted to the Kone Specific Analyser for the purpose
of recognizing, quantifying and differentiating various forms of proteinuria. Total protein, IgG, albumin and
oci-microglobulin (measured by turbidimetry), N-acetyl-ß-.D-glucosaminidase activity and creatinine (measured
photometrically), were measured in undiluted urine; in addition armicroglobulin was measured in serum.
Within and between run predsion, accuracy and linearity of the turbidimetric methods were in good agreement
with nephelometric procedures. All turbidimetric methods exhibited a correlation coefficient r > 0.98 when
compared with the radial immunodiffusion procedure äs reference method. Total protein measured turbidi-
metrically with the Kone Specific Analyser was in good agreement with the manual biuret procedure.
The low detection limits and linearities allowed quantification of urine analytes from the lower ränge of
normals up to ten times the upper limit of normals.
The measured analytes exhibited stability in urine at pH 4—8 over at least seven days at 4 —6 °C and — 20 °C.
Only IgG showed a significant loss (up to 30 percent), when measured after storage at —20 °C.
Quantities per mol creatinine showed significantly lower intra-individual and inter-individual variability than
quantities per liter. In 31 normal persons, the intraindividual Variation was lowest for N-acetyl-ß-Z>-glucosa-
minidase activity (13%) and highest for total protein (33%), when measured in the second morning urine on
5 consecutive days.
When related to creatinine, resülts obtäined in the second morning urine showed no significant differences
from those in 24 h urine, except for aj-microglobulin which gave lower values in 24 h urines.
The upper normal limits, calculated äs the 95% ranges, were determined from 154 urines of 31 individuals.
Nearly all analytes showed an asymmetric distribution. Because of a wide tailing of the upper limit, preliminary
üpper normal limits were set aböve this ränge:
Total protein: 7.9 g/mol creatinine (70 mg/g creatinine)
IgG: 1.13 g/mol creatinine (10 mg/g creatinine)
Albumin: 2.26 g/mol creatinine (20 mg/g creatinine)
ocrMicroglobulin: „ 1.58 g/mol creatinine (14 mg/g creatinine)
N^Acetyl-ß-jD-glücosaminidäse: 0.56 kU/mol creatinine (5 U/g creatinine).
Application of the newly adapted programme to unselected urines sent for urine analysis revealed a threefold
incfease in the propörtion of resülts outside the normal ranges, compared with the routinely used protein test
strip procedure. All additional positive urines exhibited either signs of glomerular or tubular proteinuria.
Determination of albumin or N-acetyl-ß-jD-glucosaminidase excretion was sufficient to detect these additional
cases.
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Introduction
Proteinuria is usually detected by qualitative tests
based either on acid precipitation or on the test strip
procedure, using the protein-error-of-indicator prin-
ciple (l, 2). These tests, however, seem not to fulfil
the medical requirements, since neither the detection
limit nor the analytical specificity allow the recogni-
tion of all clinically relevant forms of proteinuria (3,
4). This is especially true of all kinds of prerenal
proteinurias (i.e. Bence-Jones-, myoglobin-, haemo-
globin-) and tubular proteinurias, s well s so-called
microalbuminuria, all of which escape detection by
the test strip procedure (2—4). SDS-polyacrylamide
gel electrophoresis (PAGE) was proposed to over-
come this problem (5 — 7). In fact many more tubular
proteinurias were detected when this technique was
applied s a screening procedure (3,7). In spite of its
Performance, this method has not found wide appli-
cation s a routine procedure, because of its cost and
time effectiveness. We therefore tried to find an alter-
native solution to this problem by combining quan-
titative techniques for the measurement of single uri-
nary proteins of different molecular weights with es-
tablished procedures for a tubular enzyme, creatinine
and total protein (8, 9). The aim of the present di-
agnostic programme was to exclude, quantify and
differentiate various forms of proteinuria in a single
automated programme, which can be applied to un-
diluted urine samples. The present methodology has
already been partially presented in a preliminary form
(10).
and JO a.m. by 31 persons aged 18-60 years (12 men, 19
woraen) who had no anamnestic or clinical Symptoms, and no
signs of renal or other diseases. Twenty four-hour urines were
also coliected from 13 normals. The blood pressure of this
reference population was below 140/90 mmHg.
In addition 67 urines were taken from the single daiiy routine
of all surgical and medical departments of the Bogenhausen
City Hospital.
AU urines were tested with an automaieii test strip procedure
(Rapimat II, Behringwerke AG, Marburg, FRG) and found to
be negative in the reference population. The test strip pro-
gramme incl ded protein, nitrite, glucose, leukocytes, blood
and pH. All subsequent procedures were performed with su-
pernatant urines after centrifugation for 10 min at 800 g on the
same day. For stability studies urine supernatants were stored
at 4—6°C in the cool room and/or at — 20 °C in the deep
freezer.
Analytical procedures
Table l summarizes the parameters for adaptation of the fol-
lowing procedures to the Kone Specific Analyser (KONE,
Turku, Finnland).
Total protein
Protein was determined by the turbidimetric endpoint proce-
dure of Cheung et al. (9), using 0.18 mol/1 trichloroacetic acid
and 0.34 mol/1 hydrochloric acid (Merck, Darmstadt, FRG).
Undiluted urine (50 μΐ) was added to 150 μΐ of trichloroacetic
acid (reagent 1) and the turbidity signal compared with that of
parallel sample using HC1 s reagent 1. The difference was
compared with that for the Standard dflution of a control serum
(Kontrollogen®-L, Product No. 623118, Behringwerke AG,
Marburg, FRG), diluted l: 100 with 155 mmol/1 NaCl. The
Standard protein concentration (biuret proced re) was 540 mg/1,
resulting in a factor of 2763.
The biuret reaction aftef precipitation with trichloroacetic acid
(11) was used s the comparison method.
Materials and Methods
Urine samples
Urine samples (10 ml) were coliected in closed polystyrene vials
(Greiner, N rtingen, FRG). Preliminary reference ranges were
established from 154 second morning urines, voided between 8
Immunoglobulin G
IgG was determined turbidimetrically using the polyethylene-
glycol buffer (Product No. D-365, OA1) (reagent I) and anti
human IgG serum (reagent II) of Orion Diagnostica, Helsinki,
Finland (Product No. 67412/OB2). Calibrator LC-V (Behring-
werke AG* Marburg, FRG) was used s Standard. A calibration
Tab. 1. Instrumental settings for determination of the urine analytes on the Kone Specific Analyser.
Parameter
Unit
lin (1) blankvalue (2) nonlin (3)
Factor
Sample volume (μΐ)
Reagent I volume (μΐ)
Incubation time (s)
Reagent II volume (μΐ)
Incubation time (s)
Temperature (°C)
EP (1), 2-poinl (2), kin (3)
Wavelength (nm)
Measuring time (s)
Total
protein
mg/1
1
2763
50
150
320
—
—
25
1
450
—
IgG
mg/1
3
—
40
130
176
10
360
25
1
340
—
Albumin
njg/1
3
-
20
70
155
10
120
25
1
340
—
oti-Micn>
globulin
mg/1
3
-
10
130
168
20
960
25
1
340
—
N-Acetyl- -Z)-
glucosaminidase
U/l
1
25.2
22
110
450
28
30
37
1
575
-
Creatinine
rng/1
..1
1ΌΟΘ
1
99
0
90
90
25
3
510
60
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curve was constructed using concentrations of l, 3, 10, 30 and
100 mg/l respectively by dilution of the Standard with 155
mmol/1 NaCl. Radial immunodiffusion (IgG LC, Behringwerke
AG, Marburg, FRG) was used äs the comparison mcthod.
Albumin
Albumin was measured turbidimetrically äs described earlier
(12) using polyethyleneglycol (reagent 1) and anti human al-
bumin (reagent 2) from Orion Diagnostica (Helsinki, Finnland,
Product No. D748/ND1). The instrumental settings taken from
the previous publication are summarized for comparison in
table 1. Radial immunodiffusion served äs the comparison
method (albumin VLC, Behringwerke AG, Marburg, FRG).
OLi-Microglobulin
The procedure for quantifying oti-microglobulin was also
adapted by using polyethylene glycol (reagent 1) from Orion
Diagnostica (Helsinki, Finland) and anti human ai-micro-
globulin (reagent 2) from DaKoPatts, Kopenhagen, Denmark
(Product No. A256/013). For preparation of the Standard curve,
a protein Standard urine concentrate (Product No. DUUM 02/
03/049802M, Behringwerke AG, Marburg, FRG), calibrated
by radial immunodifTusion, was diluted to concentrations of 7,
14,28, 57, 114 mg/1.
Radial immunodiffusion (Behringwerke AG, Marburg, FRG)
was used äs the comparison method. ocrMicroglobulin in serum
was measured with the same analytical Programme by diluting
sera l: 10 with 155 mmol/1 NaCl.
N-acetyl-ß-D-glucosaminidasel)
The tubular enzyme activity was measured with 3-cresolsulpho-
nephthaleinyl-N-acetyl-ß-D-glucosaminide (13), using a test kit
purchased by Boehringer, Mannheim, FRG. Urine (22 ) was
mixed with 110 reagent l consisting of 2.75 mmol/1 Substrate
and 3.07 mmol/1 boräx in 50 mmol/1 potassium citrate buffer,
pH 4.75. After 450s incubation at 37 °C the reactipn was
stopped with 28 Na2CO3 (1.5 mol/1) and the absorbance read
at 575 nm after an additional 30 s. A reagent blank was run in
each series using H2O äs sample. This blank value was sub-
stracted from all samples. The factor was calculated using the
molar lineic absorbance of 4070 m2 - mol"1 for the reaction
product under the chosen conditions. This method was com-
pared with the manual procedure and with the method em-
ploying sample preparation äs described by Maruhn et al.
(8,14). The manual procedure was also compared with the
Epos Analyser (Eppendorf, Hamburg, FRG) adaptation pub-
lished previously (8).
Creatinine in urine
Creatinine was measured with the kinetic Jaffe reaction adapted
to the Kone Specific Analyser with undiluted urine, using the
reagents prepared for the mechanised version on Hitachi 705
(Boehringer, Mannheim, FRG). Urine (l ) was mixed with
99 picric acid reagent (reagent 1) and 90 NaOH (reagent
2) and the absorbance at 510 nm was read after 90 s of incu-
bation at 25 °C using the kinetic mode over 60 s. This method
was compared with the automated procedure adapted to the
Hitachi 705 using l: 20 diluted urine samples.
Control materials
Intra-assay atid inter-assay precision were detennined with Pre-
cipath U (Boehringer, Mannheim, FRG) diluted with 155
mmol/1 NaCl (total protein, IgG, albumin), protein Standard
urine concentrate (Behringwerke AG, Marburg, FRG) (armi-
croglobulin), N-acetyl-glucosaminidase Standard (Boehringer,
Mannheim, FRG) (N-acetyl-ß-£>-glucosaminidase) and Uri-
chem (Urine Chemistry Control, Human Level II) (Fisher Sci-
entific, Orangenburg, NY, USA). Accuracy was measured with
Spinal Fluid Control, Pool 150 (Fisher Scientific, Orangenburg,
NY, USA), Precipath U (Boehringer, Mannheim, FRG) and
Hitachi-calibrator (Boehringer, Mannheim, FRG), diluted
l: 100 with 155 mmol/1 NaCl (total protein), Seroquant (Beh-
ringwerke AG, Marburg, FRG) and Precipath U (Boehringer,
Mannheim, FRG), diluted l :200 with 155 mmol/l NaCl (IgG),
Spinal Fluid Control, diluted l: 2 and Kontrollogen LP (Beh-
ringwerke AG, Marburg, FRG), diluted l: 200 with 155 mmol/1
NaCl (albumin). No materials with target values were available
for Qti-microglobulin and N-acetyl-ß-£>-glucosaminidase.
Statistical evaluation
Analytical intra-assay and inter-assay precision were calculated
äs described by Keller (l 5).
The procedure to quantify intra- and inter-individual variability
described by Keller (15) for normal distributed values was
modified for non-normal distributed results. For the calculation
of the intra-individual variability, samples voided on 5 consec-
utive days from each of 31 normal persons were used. Individual
variability was calculated from the equation:
(x - x)
intraindividual variability x 100,
where
!) Enzyme: N-acetyl-ß-JP-glucosanainidase (EC 3.2.1.30)
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x = measured individual value,
n = number of independent samples,
x = median of results of one individual.
For the calculation of inter-individual variability one day of 5
was selected at random and the results for that day analysed
äs described above. Preliminary reference ranges were inde-
pendently derived from the results of 154 urines of 31 individ-
uals by determination of the 95 percentile.
Statistical significance was tested by the paired signed rank test
of Wilcoxon, Mann & Whitney (16). Linear regression analysis
was performed using the least square analysis method (16). In
addition, the general regression procedure described by Bablok
et al. was applied using the MS-DOS program version provided
by these authors (17).
Results
Adaptation of methods
The aim of the present study was to adapt a combi-
nation of türbidimetric and kinetic photometric pro-
cedures at 25 °C, and an enzyme activity determina-
tion at 37 °C to a single analyser. Using the settings
summarized in table l this was realised on a Kone
Specific Analyser. Twenty five undiluted urine samples
can be performed in l hour. As shown in table 2 the
detection limits were in the lower normal ränge for
IgG (l mg/1) and albumin (4 mg/1), while the detection
limits for total protein and N-acetyl-ß-£>-glucosamin-
idase were 10 mg/1 and l U/l respectively. Linearity
was obtained up to a concentration ten times the
upper normal limit. To exclude antigen excess äs a
possible source of error, test strip positive samples
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Tab.2. Detection and linearity limits of the methods used to measure urine analytes.
Analyte
Unit
Detection limit
Linearity limit
Total
Protein
mg/1
10
4500
IgG
mg/1
1.0
100
Albumin
mg/1
4.0
350
oti-Mücro-
globulin
mg/1
1.0
114
N-Acetyl-ß-Z)-
glucosaminidase
U/l
1.0
60
Creatinine
mmol/1
0.09
44.9
.· f
with a total protein concentration above 300 mg/1
were also measured in a l: 10 dilution with 155 mmol/1
NaCl. At protein concentrations above 4500 mg/1 a
dilution of l: 20 had to be applied. The recovery of
Standards diluted in this way was between 95 — 105%
for all proteins measured.
Analytical precision and accuracy
The intra-assay and inter-assay precisions are sum-
marized in table 3.
Intra- and inter-assay precision for the proteins were
in the usual ränge for automated nephelometric pro-
cedures, i.e. between 2.5 and 11.8%. Intra-assay Var-
iation for N-acetyl-ß-Z>-glucosaminidase was less than
4%, and inter-assay precision slightly higher. CV's at
the upper normal level were about twice äs high äs
those in the pathological ränge.
Accuracies measured with various control materials
are summarized in table 4. The deviation was between
l and 13% for total protein, IgG and albumin, i.e.
no higher than the two-fold Standard deviation of day
to day precision, although the methods used for de-
termination of the target values were not the same.
No materials with target values were available for oti-
microglobulin and N-acetyl-ß-D-glucosaminidase ae-
tivity.
Correlation with comparison methods
Figure l compares the results for the analysis of
unselected urines, using established Standard methods
and using the present method. In general, the linearity
of the present method exceeded that of the compari-
son method with no significant deviation öf the re*
sults. Conversion fäctors were between 0.92 and 1.11,
independent of the regression forimila applied (17),
with correlation coefficients between 0.980 and 0.994.
The N-acetyl-ß-Z)-glucosaminidase method of Nato
et al. (13), where gel filtration öf urine to remove
inhibitors is not necessary, showed a good correlation
with the method of Maruhn (14) (r = 0.994). The
activities measured with the Kone Specific Analyser
(or Epos Analyser), however, were almost only half
of those obtained by the method of Maruhn.
Tab. 3. Analytical precision of automated procedures for urine analytes.
Analyte
Total protein (mg/1)
IgG (mg/1)
Albumin (mg/1)
ocrMicroglobulin (mg/1)
N-Acetyl-ß-D-glucosaminidase (Ü/l)
-
Creatinine (mmol/1)
. ._
N
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
Within run
Mean
2846.0
188.0
31.1
103.4
9.8
3.2
202.4
26.4
10.6
118.0
14.7
7.0
19.6
6.0
1.9
16.9
8.0
1.6
SD
74.9
6.0
3.7
2.8
0.3
0.1
11.7
0.8
0.3
3.5
0.6
0.4
0.2
0.1
0.1
0.3
0.2
0.1
CV
(%)
2.6
3.2
11.8
2.7
3.1
4.2
5.8
3.0
2.5
2.9
4.2
6.0
1.1
1.8
3.8
2.0
2.9
4.5
Between run
Mean
2660.0
172.0
26.0
113.7
10.5
3.5
236,0
24.8
9.3
142.1
15.5
7.2
20.0
6.2
2.4
16.1
7.9
1.6
SD
64.0
6.2
4.1
4.1
0.8
0.4
9.3
1,2 .
0.7
4.8
1.2
0.8
0.8
0.3
. 0.2
0.6
0.3
0.1
CV
(%)
2.4
3.6
15.6
3.6
7.5
10.5
3.9
4.8
7.2
3.4
7.8
10.7
4.2
4.8
7.1
3.7
3.8
6.3
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Tab. 4. Accuracy of automated procedures for urine analytes.
Analyte
Total protein
IgG
Albumin
Material
Spinal Fluid Control
Precipath U (1 : 100)
Hitachi Cal. (1 : 100)
Seroquant (1 : 200)
Precipath U (1 : 200)
Spinal Fluid Control (1 : 2)
Kontrollogen LP (1:200)
Beckman Cal. (1 : 200)
Method used for target value
Trichloroacetic acid 30; 125 g/l
Biuret
Biuret
RID
turbidimetric
electrophoretic*
Bromocresylgreen
nephelometric
Target
value
mg/1
570
575
520
61
45
197
200
210
Result
mg/1
588
571
532
63
51
206
205
211
Difference
mg/1
18
4
12
2
6
9
5
1
Deviation
%
+ 3.2
- 0.7
+ 2.3
+ 3.3
4-13.3
+ 4.6
+ 2.5
+ 0.5
electrophoretic analysis (agarose gel), calculation based upon a total protein of 580 mg/1
Stability of urine analytes
The stability of the urine analytes was measured at
4 °C and —20 °C over 20 days. No significant changes
were found for albumin and ocrmicroglobulin (18)
over 7 days at 4 °C and 20 days at -20 °C. In ac-
cordance with previous reports of others (19), N-
acetyl-ß-D-glucosaminidase activity was stable over
more than 7 days at both temperatures. Only IgG
showed a decrease (up to 30%), when measured in
samples stored frozen, whereas no change was found
at 4 °C (18). Samples were therefore stored at 4-6 °C
for up to 7 days, if determinations were not performed
on the same day.
Biological variability and reference ranges
The biological variability calculated from second
morning urines on 5 consecutive days was studied in
31 normal persons. The intra- and inter-individual
biological variabilities obtained are summarized in
table 5. It can be seen that the biological inter- and
intra-individual variability were much lower if the
values were related to creatinine. Inter-individual var-
iability was between 1.8 and 2.2 times higher than
intra-individual variability. N-Acetyl-ß-£>-glucosa-
minidase exhibited the lowest biological variability,
followed by aj-microglobulin, albumin, IgG and total
protein.
The preliminary 95% limits were:
second morning urine
total protein:
6.3 g/mol creatinine (55.7 mg/g creatinine)
IgG:
0.77 g/mol creatinine (6.8 mg/g creatinine)
albumin:
1.34 g/mol creatinine (11.8 mg/g creatinine)
-microglobülin:
1.49 g/mol creatinine (13.2 mg/g creatinine)
N-acetyl-ß-Z>-glucosaminidase:
0.47 kU/mol creatinine (4.2 U/g creatinine)
Tab. 5. Biological variability pf analytes in urine.
Intra-individual Inter-individual
Total ,protein
IgG
Albumin
oci-Microglobulin
N-Acetyl-ß-/)-
glucosamimdase
Creatinine
per 1
36
29
29
26
16
20
per mol per 1
creatinine
33
25
22
20
13
71
69
71
71
36
50
per mol
creatinine
72
44
43
44
29
Intra- und intei>individual variabilities were calculated äs de-
scribed in the methods seetion. The results given represent the
raeans of deviatiön äs percent of the median of all determina-
tions.
serum
oti-microglobulin:
25-100 mg/1.
Because nearly all analytes showed an asymmetric
distribution pattein with a tailing (fig. 2), a somewhat
higher "normal" limit is suggested
total protein:
7.9 g/mol creatinine (70 mg/g creatinine)
IgG:
1.13 g/mol creatinine (10 mg/g creatinine)
albumin:
2.26 g/mol creatinine (20 mg/g creatinine)
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Fig. \. Comparison of resiüts from the present analytical procedures with those from established comparison methods.
20-74 unselected urines were analysed with the present programme and with the comparison methods (in brackets).
Linear regression was calculated by the method of least squares (16) and by the method of Bablok et al. (17). The arrows
indicate the concentration at which samples were diluted.
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ai-microglobulin:
1.58 g/mol creatinine (14 mg/g creatinine)
N-acetyl-ß-D-glucosaminidase:
0.56 kU/mol creatinine (5 U/g creatinine).
No significant differences were observed between
males and females.
Comparison between second morning urine
and 24 hour urine
In view of the large variability of urine composition,
the present parameters were measured in normal per-
sons in spontaneous urine samples (second morning
urine voided between 8 — 10 a. m.) and the results
compared with those from a 24 hour urine sample
collected on the same day.
Table 6 summarizes the results obtained in 13 normal
persons.
When tested with the paired signed rank test of Wil-
coxon, Mann & Whitney (16) no significant differences
between analyte concentrations in second morning
urine and 24 h urines were found for total protein,
IgG and albumin, whereas -microglobulin and N-
acetyl-ß-Z>-glucosaminidase activity exhibited signifi-
cant differences.
When related to creatinine the differences between
the two urines were no longer significant except in
the case of o^-microglobulin.
Use of the new diagnostic program äs screen-
ing procedure
In order to test the diagnostic Utility of the present
Programme, 67 unselected urines from a daily routine
were analysed and the results compared with the
results of the usual test strip procedure. The results
are summarized in table 7a,bc. As can be seen, 13
out of 67 (19%) gave a positive test strip result for
proteinuria. When analysed with the present analyti-
cal Programme, 37 out ot 67 urines (55%) gave at
least one result outside the normal ränge. All five
assays revealed nearly the same number of positive
answers. Of the 28 urines with an elevated albumin
only 12 gave a positive test strip result for protein.
Of these 28 urines, 25 exhibited a simultanous eleva-
tion of IgG, 21 of aj-microglobulin and 20 of N-
acetyl-ß-Z>-glucosaminidase. Total protein was ele-
vated together with albumin in 24 out of 28 urines.
Twenty eight urines showed an elevated N-acetyl-ß-
Z>-glucosaminidase activity. All the other analytes
were also elevated in 71 —76% of these urines. Only
36% of the urines showing increased N-acetyl-ß-Z)-
glucosaminidase gave a positive protein test strip re-
sult.
When albumin and N-acetyl-ß-£>-glucosaminidase
were combined, 36 urines exhibited at least one po-
sitive result outside the normal ränge. This combi-
nation provided the highest rate of recognition of
glomerular and tubular dysfunction. In comparison,
only 33 urines exhibited an elevation of total protein
and/or N-acetyl-ß-Z>-glucosaminidase, 33 showed an
elevation of albumin and/or aj-microglobulin, and 30
showed an elevation of total protein and/or albumin.
The number for other combinations was less than 30.
In order to test the diagnostic Utility of the present
prograinme for excluding haematuria and leukocy-
turia, the results were compared with those of the
respective test strip field (tab. 7c).
Eighteen urines were positive for the blood test strip.
In 17 of these urines IgG was elevated. Similarly high
numbers of positives were found for total protein and
albumin.
a. total protein (manual biuret procedure)
linear regression: n = 22; r = 0.994
y = -35 4- 0.92x
Bablok et al.: y = -41 4- 0,93x
b. IgG (radial immunodiffusion method)
linear regression: n = 20; r = Q.986
y= -0.6 4- 1.07x
Bablok et al,: y = -1.1 + l.OSx
c. albumin (radial immunodiffusion method)
linear regression: n = 30; r = 0.992
y= -1.3 4- l.Olx
Bablok et al.: y = -^1.8 4- 1.02x
d. armicoglobulin (radial immunodiffusion method)
linear regression: n = 40; r = 0.980
y= -1.8 + l.llx
Bablok et al.: y = -2.5 4- 1.14x
e. N-acetyl-ß-/>-glucosaminidase. The present method
was compared with a previously published adapta-
tion of the Noto procedure (13) to the Epos analyser,
which was also compared with the manual method
of Maruhn et al. (14) using nitrophenyl derivatives
äs Substrate, with gel filtration (8).
Epos/Maruhn
linear regression: n = 59; r = 0.994
y = 0.15 + 0.42x
Bablok et al.: y = 0.11 H- 0.42x
Epos/Kone
linear regression: n = 73; r = 0.999
y = 0.01 + 0.94x
Bablok et al.: y = 0.01 H- 0.94x
f. creatinine (Jaffe kinetic, Hitachi 705, using l: 20
diluted urine samples)
linear regression: n = 74; r = 0.991
y = 0.20 + 0.94x
Bablok et al.: y = 0.12 4- 0.95x
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Fig. 2. Distribution of results in urines and sera from a normal population.
154 second morning urines and 31 sera from 31 normal persons (see methods for age and sex distribution) were analyzed
with the procedures described in the methods section and the results expressed in relation to the creatinine concentration
in the same sample.
Analyte N Medi n 95th percentile
a. Total protein (g/mol creatinine)
b. IgG (g/mol creatinine)
c. Albumin (g/mol creatinine)
d. ott-Microglobulin (g/mol creatinine)
e. N-acetyl- -D-glucosaminidase (kU/mol creatinine)
f. αι-Microglobulin, serum (mg/1)
154
153
154
154
154
24
1.6
0.4
0.95
0.59
0.22
60
6.3
0.77
1.34
1.49
0.47
86
arMicroglobulin and N-acetyl- -Z>-glucosaminidase
activity were raised in 14 and 13 cases respectively.
The leukocyte test strip was positive in 32 urines.
Nine of these urines showed no positive result outside
the reference ranges in the present programme. Total
protein and N-acetyl- -Z)-glucosaminidase were
raised in 18 urines (56%), albumin and ocrmicroglob-
ulin in 19 cases (59%) and IgG in 21 (66%).
Discussion
The present st dy was performed to establish a fully
automated programme fof scfeening and differentia-
tion of proteinuria in a routine laboratory. The ana^
lytes chosen allow the recognition of all types of
glomerular and tubulaf proteinuria. In contrast, the
test strip prpcedure for screening for proteinuria, al-
though relatively specific for albumin, detects this
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Tab. 6. Comparison of excretion rates in second morning and 24 h urine from 13 normal persons.
Second morning urine 24 hour urine
median ränge median ränge
IgG
mg/1 5.2 2.6-11.3
g/mol creatinine 0.42 0.22-1.00
Albumin
mg/1 10.5 <4-18.4
g/mol creatinine 0.65 < 0.45 -1.11
,-Microglobulin
mg/1 10.2 4.5-34.8
g/mol creatinine ' 0.99 0.22 -1.74
N-Acetyl-ß-/)-glucosaminidase
U/l 3.6 1.2-6.3
kU/mol creatinine 0.25 0.11 - 0.48
Creatinine
mmol/1 14.9 3.0-25.8
3.8
0.25
5.8
0.53
8.2
0.65
2.9
0.28
10.9
1.1-10.4
0.13-0.64
< 0.45-1.05
2.4-30.4
0.27-1.89
1.7-5.8
0.18-0.40
6.8-16.1
Bias
Total protein
mg/1
g/mol creatinine
31
1.7
10-55
1.1-10.9
11 <10-20
<1.1 <1. 1-1.8
4-20
-h 1.4
+ 0.17
+ 4.7
+ 0.12
+ 2.0*
-l· 0.34**
+ 0.7**
- 0.03
+ 4.0
* = 0.001
** = 0.05
Excretion of the analytes was measured in second morning and 24 h urine samples on the same day. Statistical significance of
difTerences (bias) was tested by the paired signed test of Wilcoxon, Mann & Whitney (16).
protein at an excretion rate 10 times above normal
(l, 3, 4). In addition prerenal and tubular proteinuria
are not detected by the protein-error-of-indicator
principle (l, 4). The polyacrylamide gel electropho-
resis technique, which separates proteins according to
their relative molecular mass, was therefore propa-
gated to detect and differentiate these different forms
(5, 6, 7). In fact when applied in a screening pro-
gramme many more prpteinurias were detected, pri-
marily of the tubular type (20).
In contrast to this technique, the presently used quan-
titative measurement of characteristic proteins gives
additional Information abput the degree of tubular
and glomerular proteinuria. The present programme
of analytes was choseii to combine the sensitivity of
the electrophoretic procedure with the advantages Pf
quantification and automation. In addition, by in-
cluding the automated measurement öf N-acetyl-ß-D-
glucosaminidase and creatinine, the present profile
yields rriPre Information than previously süggested
regimes. The automated assay of N-acetyl-ß-D-glu-
cpsaminidase was proposed äs a screening procedure
by fucker et al. (21).
Polyacrylamide^gel-electrophoresis seems more suit-
able only for the detection of prerenal proteinuria
such äs myoglobinuria and Bence-Jones-proteirmna,
(22). Recent experience with urines of patients with
monoclonal gammopathies (23) has shown that these
forms can be recognized from the discrepancy between
total protein and albumin, and that they simultane-
ously exhibit an elevated N-acetyl-ß-D-glucosamini-
dase activity and o^-microglobulin concentration (24).
Biological Variation of urinary proteins
Other investigators have reported the biological day
to day Variation of urinary analytes. Thus Hemming-
sen & Skaarup (25) found that albumin varied day to
day by 31%, IgG by 26%, and lysozyme by 36%. In
studies on 24 h urines Bingham et al. (26) found intra-
individual variations for urine analytes between
10.7% (creatinine) and 30.5% (sodium). For albumin,
measured in urines of normal persons, Viberti et al.
(27, 28) found ä large intra-individual Variation,
which was pnjy slightly less when related to creatinine.
Calculation of urinary enzyme activities, in relation
to creatinine reduced the intra-individual variabilities
(29, 30, 31). Our present results confirm and extend
these pbservations. When compared with concentra-
tions, excretion rates related to creatinine showed
slightly but significantly lower biological variations.
This may however limit the diagnostic value in situ-
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Tab. 7. Comparison of present analytical profile with test strip procedure for screening unselected urines.
a) Total results
n = 67
Positive
Negative
Protein
test strip
13
54
Blood
18
49
Leuko-
cyte
32
35
Glucose
3
64
Total
protein
26
41
IgG
28
39
Albu-
min
28
39
oti-Micro-
globulin
26
41
N-Acetyl-;ß-£>-
glucosaminidase
28
39
b) Urines with increased albumin and N-acetyl-ß-jD-glucosaminidase excretion
1. albumin > 2.26 g/mol creatinine (20 mg/g creatinine)
n = 28
Positive
Negative
Total protein
24
4
IgG
25
3
Oi-Micro-
globulin
21
7
N-AcetyUß-i)-
glucosaminidase
20
8
Protein test strip
12
16
2. N-Acetyl-ß-Z>-glucosaminidase > 0.56 kU/mol creatinine (5 U/g creatinine)
n = 28 Total protein IgG Albumin oci-Microglobulin Protein test strip
Positive
Negative
21
7
22
6
20
8
22
6
11
17
3. Combination
albumin > 2.26 g/mol creatinine (20 mg/g creatinine)
and N-acetyl-ß-jD-glucosaminidase > 0.56 kU/mol creatinine (5 U/g creatinine)
n = 36
Positive
Negative
Total protein
26
10
IgG
27
9
Albumin
28
10
-Micro-
globulm
24
12
N-Acetyl-ß-i)-
glucosarainidase
28
10
Protein test strip
21
15
c) Urines with positive blood and/or leukocyte test strip field
1. blood test field positive
n = 18 Total protein IgG
2. leukocyte test field positive
n = 32 Total protein IgG
Albumin
Albumin
cci-Microglobulin
glucosaminidase
Positive
Negative
16
2
17
1
16
2
14
4
13
5
(Xi-Microglobulin N-Acetyl-ß-D-
glucosaminidase
Positive
Negative
18
14
21
11
19
13
19
13
18
14
ations where urine creatinine is highly variable, äs in
pediatric urines (32), athletes (Hofmann, W., Beuker,
F. & Guder, W. G. unpublished observations) and in
acute renal failure (33). As expected, the intra-indi-
vidual variability was much lower than the inter-
individual variability. Compared with the biological
Variation of serum parameters (34), the variability for
urinary parameters was much higher. This can be
expected for an open System like urine where many
niore physiological influences, like fluctuating filtra-
tion rates, changing reabsorption arid catabolism
must be considered.
Remarkably the biological variability for iSf-acetyl-ß-
£)-glucosaminidase was only half of thät öf the other
proteins. This might be explained by the fact thät
IgG, albumin and a^microglobulin are filtered in
varying amoünts through the glomerülar basal mem-
J. Clin. Chem. Clin. Biochem. / Vol. 27,1989 / No. 9
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brane. Haemodynamic factors like blood pressure and
different reabsorption rates of high and low molecular
weight proteins influence the excretion rates of these
tested proteins (20). In contrast N-acetyl-ß-Z)-glucos-
aminidase is added to the urine by the turnover of
cells. This process has been shown to proceed period-
ically (35).
Selection of sample
For qualitative sereening purposes the first morning
urine is generally used, whereas 24 h urine sampling
is suggested for quantitative urine determinations
(36). With regard to urine protein and enzyme activity
determination, no uniform recommendations exist in
the literature (19, 27, 29, 35, 37).
Our observation that second morning urine and 24 h
urine showed no significant differences when results
were related to creatinine makes it possible to substi-
tute the 24 h urine for the second morning urine. This
circumvents the problem of quantitative urine collec-
tion (26). The second morning urine has additional
advantages because of its higher practicability in am-
bulatory sereening. Sauer et al. (38), Gatling et al.
(39) and Watts et al. (40) showed, for diabetics, that
morning urine has the same diagnostic efficiency for
the recognition of microalbuminuria äs an overnight
or twenty-four hour urine. Jung & Schulze (30), Bur-
chardt et al. (35) and Schulze & Goebel (41) reported
investigations on the determination of urine enzyme
activities in second morning urine related to creati-
nine. According to their conclusion, inactivation of
enzymes could be avoided and different excretion
rates corrected.
Application of the present programme äs a
sereening procedüre
Application of the present programme äs a sereening
procedüre resulted in the expected higher number of
positive results. These additional "positives" were
mainly due to albuminuria below the detection limit
of the test strip, tubular proteinurias and urines with
increased N-acetyl-ß-£>-glucosaminidase activity and
IgG excretion. Albumin and N-acetyl-ß-D-glucosa-
minidase, when used äs the only criteria, were able to
detect 97% of all urines positive in one of the analytes
quantified. Therefore these two parameters seem to
be sufficient for excluding clinically relevant glomer-
ular and tubular forms of proteinuria.
From the other test strip procedures only the leuko-
cyte test field resulted in additional positive answers,
whereas more than 90% of urines with haematuria
exhibited at least one result outside the reference ränge
when the present profile was applied. As a preliminary
conclusion it seems advisable to add a test for leu-
kocytes to the present profile to exclude infectious
diseases of the urinary tract.
Future aspects and conclusions
The present programme seems to be sufficiently sen-
sitive for the detection of all clinically relevant types
of glomerular and tubular proteinuria. To differen-
tiate between prerenal and renal types of proteinuria
the present concept has to be tested in special patient
groups. By setting the decision limits outside the nor-
mal ränge, it is possible to differentiate and monitor
various forms of clinical nephropathies. In addition,
ratios between the measured analyte concentrations
may be used diagnostically; such ratios have already
beeen successfully applied in the analysis of liver dis-
eases (42) and spinal fluid analysis (43). As long äs
23 years ago, Cameron & Blandford proposed the use
of analyte ratios in urine analysis (44).
In conclusion the present programme offers the pos-
sibility of screening large numbers of urine samples
by quantitative analysis with little additional to the
work load. Reagent costs can be kept within the ränge
of those for routine clinical chemistry procedures by
using the present strategy.
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